Join
Live feed
·
INSIDERFilingvia Quantisnow
Aeglea BioTherapeutics Inc. logo

Albers Jeffrey W. converted options into 34,360 shares (SEC Form 4) (Amendment)

ByQuantisnow·Wall Street's wire, on your screen.
AGLE· Aeglea BioTherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGLE (Aeglea BioTherapeutics Inc.) and more on Quantisnow.

Albers Jeffrey W. converted options into 34,360 shares (SEC Form 4) (Amendment) | Quantisnow